Segulah IV L.P. has entered into an agreement to sell 100% of the shares in Medstop Group Holding AB to Oriola-KD Holding Sverige AB. The transaction is subject to the approvals of the Swedish Competition Authority (Konkurrensverket) and the Swedish Medical Products Agency (Läkemedelsverket). If and when the transaction closes, an Early Redemption Event will occcur according to the Terms & Conditions, which gives Medstop the right to redeem the notes and the Noteholders the option to request a redemption of the Notes. CorpNordic has a dialogue with Medstop and will keep the Noteholders informed.
For further information please contact Jolande Svensson-Klijn.